Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-20-048883

Chief Financial Officer sold 509 shares at $22.82 ($11,615)

  • Chief Financial Officer acquired 1,042 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PFREUNDSCHUH PETER P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-01 Exercise or conversion : show line 1 in the form +1,042 8,397 D
2020-09-01 Sale : show line 2 in the form −509 $22.82 $11,615 7,888 D
Open-market sales · 509 sh · avg $22.82 · $11,615

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-09-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,042 1,042 4,166 D
Loading xslF345X03/doc4.xml…